# Test Albuvirtide in Experienced Patients

> **NCT02369965** · PHASE3 · COMPLETED · sponsor: **Frontier Biotechnologies Inc.** · enrollment: 418 (actual)

## Conditions studied

- HIV Infections
- AIDS

## Interventions

- **DRUG:** albuvirtide
- **DRUG:** lopinavir-ritonavir
- **DRUG:** tenofovir
- **DRUG:** lamivudine

## Key facts

- **NCT ID:** NCT02369965
- **Lead sponsor:** Frontier Biotechnologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-19
- **Primary completion:** 2018-04-02
- **Final completion:** 2018-04-02
- **Target enrollment:** 418 (ACTUAL)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02369965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02369965, "Test Albuvirtide in Experienced Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02369965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*